Celiac disease and its link to type 1 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 14, Issue SUPPL. 1, 2001, Pages 597-605

  Schuppan, Detlef ^a   Hahn, Eckhart G ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NONE

Author keywords

Autoantigens; Celiac disease; Gliadin; Gluten; HLA loci; T cells; Transglutaminase; Type 1 diabetes mellitus

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EPITOPE; GLUTEN; HLA DQ ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELIAC DISEASE; CEREAL; CONTROLLED STUDY; CORRELATION FUNCTION; DEVELOPMENT; DIET; DISEASE ASSOCIATION; DISEASE COURSE; EXPOSURE; GASTROINTESTINAL SYMPTOM; GENE LOCUS; GENE MAPPING; GENETICS; HUMAN; IMMUNE SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE MUCOSA; MALABSORPTION; PREVALENCE; PROTEIN PROCESSING; SMALL INTESTINE DISEASE; SYMPTOM;

EID: 0035020867     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.2001.14.s1.597     Document Type: Article

References (47)

1. Trier JS. Diagnosis of celiac sprue. Gastroenterology 1998; 115: 211-216.
2. Catassi C, Ratsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, Coppa GV, Giorgi PL. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994; 343: 200-203.
3. Meloni G, Dore A, Fanciulli G, Tanda F, Botazzo GF. Subclinical coeliac disease in school children from Northern Sardinia. Lancet 1999; 353: 37.
4. Noth T, Horvath K, Hill I, Partanen J, Hammed A, Magazzu G, Fasano A. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 1998; 33: 494-498.
5. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Med 1997; 3: 797-801.
6. Greenberg CS, Birkbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991; 5: 3071-3077.
7. Piacentini M, Colizzi V. Tissue transglutaminase: apoptosis versus autoimmunity. Immunol Today 1999; 3: 130-134.
8. Schuppan D, Ehnis T, Bauer M, Volta A, Donner P, Riecken EO, Dieterich W. Identification of the autoantigen of coeliac disease. Ann NY Acad Sci 1998; 859: 121-126.
9. Bruce SE, Bjarnason I, Peters TJ. Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin Sci 1985; 68: S73-S79.
10. Szabolcs M, Sipka S, Csorba S. In vitro cross-linking of gluten into high molecular weight polymers with transglutaminase. Acta Paediatr Hung 1987; 28: 215-227.
11. Molberg Ø, McAdam SN, Korner R, Quarsten H, Christiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KEA, Sjøstrom H, Sollid L. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Med 1998; 4: 713-717.
12. Van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G, Koning F. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998; 161: 1585-1588.
13. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nature Med 2000; 6: 337-342.
14. Arentz-Hansen H, Korner R, Molberg Ø, Quarsten H, Vader M, Kooy YM, Lundin KE, Koning F, Roepstorff P, Sollid LM, McAdam SN. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000; 191: 603-612.
15. Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, Sollid LM. Gliadin-specific, HLA-DQ (alpha*0501, beta*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993; 178: 187-196.
16. Sollid LM. Autoantibodies in coeliac disease: tissue transglutaminase - guilt by association? Gut 1997; 47: 851-852.
17. Pender SL, Tickle SP, Docherty AJ, Howie D, Wathen NC, McDonald TT. A major role of matrix metalloproteinases in T cell injury in the gut. J Immunol 1997; 158: 1582-1590.
18. Schuppan D, Dieterich W, Riecken EO. Exposing gliadin as a tasty food for lymphocytes. Nature Med 1998; 4: 666-667.
19. Schuppan D. Novel concepts of coeliac disease pathogenesis. Gastroenterology 2000; 119: 234-242.
20. Daum S, Bauer U, Foss HD, Schuppan D, Stein H, Riecken EO, Ullrich R. Increased expression of mRNA for matrix metalloproteinase-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 1999; 44: 17-25.
21. Cronin CC, Shanahan F. Insulin-dependent diabetes mellitus and coeliac disease. Lancet 1997; 349: 1096-1097.
22. Seissler J, Schott M, Boms S, Wohlrab U, Ostendorf B, Morgenthaler NB, Scherbaum WA. Autoantibodies to tissue transglutaminase identify silent coeliac disease in type 1 diabetes. Diabetologia 1999; 42: 1441-1442.
23. Kordonouri O, Dieterich W, Schuppan D, Weber G, Müller C, Sarioglu N, Becker M, Danne T. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent celiac disease in patients with type 1 diabetes mellitus. Diabetic Med 2000; 17: 441-444.
24. Hummel M, Bonifacio E, Stern M, Dittler J, Schimmel A, Ziegler AG. Development of celiac disease-associated antibodies in offspring of parents with type 1 diabetes. Diabetologia 2000; 43: 1005-1011.
25. Houlston RS, Tomlinson IP, Ford D, Seal S, Marossy AM, Ferguson A, Holmes GK, Hosie KD, Howdle PD, Jewell DP, Godkin A, Kerr GD, Kumar P, Logan RF, Love AH, Johnston S, Marsh MN, Mitton S, O'Donoghue D, Roberts A, Walker-Smith JA, Stratton MF. Linkage analysis of candidate regions for celiac disease genes. Hum Mol Genet 1997; 6: 1335-1339.
26. Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers M, Eisenbarth GS. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 1999; 13: 143-148.
27. Schenker M, Hummel M, Ferber K, Walter M, Keller E, Albert ED, Janka HU, Kastendiek C, Sorger M, Louwen F, Ziegler AG. Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with type 1 diabetes: the German BABYDIAB study. Diabetologia 1999; 42: 671-677.
28. Galli-Tsinopoulou A, Nousia-Arvanitakis S, Dracoulacos D, Xefteri M, Karamouzis M. Autoantibodies predicting diabetes mellitus type 1 in celiac disease. Horm Res 1999; 52: 119-124.
29. Saukkonen T, Savilahti T, Reijonen H, Ilonen J, Tuomilehto-Wolf E, Åkerblom HK. Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus. Childhood Diabetes in Finland Study Group. Diabetic Med 1996; 13: 464-470.
30. Westman E, Ambler GR, Royle M, Peat J, Chan A. Children with coeliac disease and insulin-dependent diabetes mellitus - growth, diabetes control and dietary intake. J Pediatr Endocrinol Metab 1999; 12: 433-442.
31. Acerini CL, Ahmed ML, Ross KM, Sullivan PB, Bird G, Dunger DB. Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten-free diet. Diabetic Med 1998; 15: 38-44.
32. Meddings JB, Jarand J, Urbanski SJ, Hardin J, Gall DG. Increased gastrointesinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol 1999; 276: G951-957.
33. Funda DP, Kaas A, Bock T, Tlaskalova-Hogenova H, Buschard K. Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev 1999; 15: 323-327.
34. Ventura A, Magazzu G, Greco L, and the SIGEP study group. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999; 117: 297-303.
35. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1999; 7: 335-343.
36. Cookson WOCM, Moffatt MF. Asthma: an epidemic in the absence of infection? Science 1997; 275: 41-42.
37. Erb K. Atopic disorders: a default pathway in the absence of infection? Immunol Today 1999; 7: 317-322.
38. Ladinser B, Rossipal E, Pittscjieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994; 35: 776-778.
39. Corrao G, Corazza GR, Andreani ML, Torchio P, Valentini RA, Galatola G, Quaglino D, Gasbarrini G, di Orio F. Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut 1994; 35: 771-775.
40. Dieterich W, Laag E, Schöpper H, Volta U, Ferguson A, Gillet H, Riecken EO, Schuppan D. Autoantibodies to tissue transglutaminase as predictors of coeliac disease. Gastroenterology 1998; 115: 1317-1321.
41. Sulkanen, S, Halttunen, T, Laurila, K, Kolho KL, Korponay-Szabo IR, Sarnesto A, Savilahti E, Collin P, Mäki M. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322-1328.
42. Troncone R, Maurano F, Rossi M, Micillo M, Greco L, Auricchio R, Salerno G, Salvatore F, Sacchetti L. IgA antibodies to tissue transglutaminase: an effective diagnostic test for celiac disease. J Pediatr 1999; 134: 166-171.
43. Seissler J, Borns S, Wohlrab U, Morgenthaler NG, Mothes T, Boehm BO, Scherbaum WA. Antibodies to human tissue transglutaminase measured by radioligand assay: evidence for high diagnostic sensitivity for celiac disease. Horm Metab Res 1999; 31: 375-379.
44. Lampasona V, Bonfanti R, Bazzigaluppi E, Venerando A, Chiumello G, Bosi E, Bonifacio E. Antibodies to tissue transglutaminase C in type 1 diabetes. Diabetologia 1999; 42: 1195-1198.
45. Sardy M, Odenthal U, Karpati S, Paulsson M, Smyth N. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem 1999; 45: 2142-2149.
46. Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, Fasano A, Ventura A, Not T. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol 2000; 98: 1253-1257.
47. Mustalahti K, Collin P, Sievanen H, Mäki M. Osteopenia in patients with clinically silent celiac disease. Lancet 1999; 354: 744-745.